Providence Therapeutics Employee Directory
Biotechnology ResearchAlberta, Canada51-200 Employees
Providence Therapeutics Holdings Inc is a clinical-stage biotechnology company based in Calgary, Alberta, focused on advancing drugs and platform technologies. It operates an integrated mRNA medicines framework built from three platforms—the mRNA Medicines Platform, the INTENT LNP Platform, and a Manufacturing Platform—enabling end-to-end design of codon-optimized, ultrapure mRNA that can be formulated within optimized lipid nanoparticles. The INTENT LNP platform comprises rationally designed lipids evaluated for potential use in oncology, infectious diseases, and gene delivery, with an emphasis on targeted tissue delivery. The firm traces its origins to 2015, when it began as a cancer vaccines company, and has since broadened its focus into mRNA medicines and platform development. It has pursued collaborations with research and clinical partners, including a 2023 alliance with University Health Network to explore new mRNA vaccines and therapies for difficult cancers and infectious diseases, and a 2025 partnership with Southern RNA Pty to advance personalized cancer vaccines and RNA-based therapeutics.
1-888-653-2347 
support@leadiq.com 
